サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1767670

ロサルタン市場：適応症別、濃度別、製品種類別、年齢層別、性別、流通チャネル別、形状別、供給源別、地域別

Losartan Market, By indication, By Strength, By Product Type, By Age Group, By Gender, By Distribution Channel, By Form, By Source, By Geography

出版日
ページ情報
英文 165 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.39円
ロサルタン市場：適応症別、濃度別、製品種類別、年齢層別、性別、流通チャネル別、形状別、供給源別、地域別
出版日: 2025年06月23日
発行: Coherent Market Insights
ページ情報: 英文 165 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ロサルタンの市場規模は2025年に16億8,000万米ドル、2032年には22億3,000万米ドルに達し、2025年から2032年までの年間平均成長率（CAGR）は4.1%と予測されています。

分析範囲 分析詳細
基準年 2024年 市場規模 (2025年) 16億8,000万米ドル
実績データ 2020～2024年 予測期間 2025～2032年
予測期間のCAGR (2025～2032年) 4.10% 予測金額 (2032年) 22億3,000万米ドル

世界のロサルタン市場は、世界の高血圧と心血管疾患の有病率の増加に牽引され、近年著しい成長を遂げています。アンジオテンシンII受容体拮抗薬であるロサルタンは、高血圧、心不全、糖尿病性腎症の治療薬として広く処方されています。市場の拡大には、不健康なライフスタイルや効果的な血圧管理の重要性に対する意識の高まりがさらに拍車をかけています。さらに、ロサルタンのジェネリック医薬品が入手しやすくなり、価格も手頃になったことも普及に寄与しています。効率的な降圧薬への需要が高まり続けていることから、世界のロサルタン市場は今後数年で大きく成長するものと思われます。

市場力学

世界のロサルタン市場は、いくつかの主要な促進要因、市場抑制要因、機会によって影響を受けています。市場成長の主な促進要因は、高血圧と心不全や脳卒中などの関連心血管系疾患の有病率の増加です。座りがちな行動、肥満、高ストレスレベルを特徴とする不健康なライフスタイルは、高血圧の発生率の大幅な上昇につながっています。さらに、効果的な血圧管理の重要性に対する意識の高まりと、手頃な価格のロサルタンジェネリック医薬品の入手可能性が、市場の成長を後押ししています。しかし、代替降圧薬の存在やロサルタンの使用に伴う潜在的な副作用など、市場には一定の抑制要因もあります。さらに、ブランド・ロサルタン製品の特許切れによりジェネリック・メーカーとの競争が激化し、主要プレイヤーの市場シェアに影響を与える可能性があります。このような課題にもかかわらず、市場は新規ドラッグ・デリバリー・システムの開発、ロサルタンの治療用途の拡大、高血圧有病率の高い新興経済諸国における未開拓の可能性など、有望な成長機会を提示しています。さらに、製薬企業間の戦略的提携や合併により、今後数年間は技術革新が促進され、市場範囲が拡大すると予想されます。

当レポートの主な特徴

  • 当レポートは、世界のロサルタン市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
  • また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 世界のロサルタン市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
  • 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
  • 「世界のロサルタン市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
  • 利害関係者は、世界のロサルタン市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

  • 分析目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学・規制・動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向
  • 治療オプション分析
  • 薬剤耐性シナリオ
  • 償還シナリオ
  • 規制シナリオ

第4章 世界のロサルタン市場：適応症別（2020～2032年）

  • 高血圧
  • 左室肥大（LVH）
  • 糖尿病性腎症
  • その他（脳卒中など）

第5章 世界のロサルタン市場：濃度別（2020～2032年）

  • 5mg
  • 25mg
  • 50mg
  • 100mg

第6章 世界のロサルタン市場：製品種類別（2020～2032年）

  • ブランド
  • ジェネリック

第7章 世界のロサルタン市場：年齢層別（2020～2032年）

  • 小児
  • 成人
  • 高齢者

第8章 世界のロサルタン市場：性別（2020～2032年）

  • 男性
  • 女性

第9章 世界のロサルタン市場：流通チャネル別（2020～2032年）

  • 病院薬局
  • 小売薬局
  • オンライン薬局

第10章 世界のロサルタン市場：形状別（2020～2032年）

  • 錠剤
  • 粉末
  • 懸濁液

第11章 世界のロサルタン市場：供給源別（2020～2032年）

  • 契約製造組織
  • 社内製造

第12章 世界のロサルタン市場：地域別（2020～2032年）

  • 北米
      • 米国
      • カナダ
  • ラテンアメリカ
      • ブラジル
      • アルゼンチン
      • メキシコ
      • その他ラテンアメリカ
  • 欧州
      • ドイツ
      • 英国
      • スペイン
      • フランス
      • イタリア
      • ロシア
      • その他欧州
  • アジア太平洋
      • 中国
      • インド
      • 日本
      • オーストラリア
      • 韓国
      • ASEAN
      • その他アジア太平洋
  • 中東
      • GCC諸国
      • イスラエル
      • その他中東
  • アフリカ
      • 南アフリカ
      • 北アフリカ
      • 中央アフリカ

第13章 競合情勢

  • Teva Pharmaceutical Industries Ltd
  • Mylan N.V.
  • Organon LLC
  • Alembic Pharmaceuticals Ltd
  • Macleods Pharmaceuticals Ltd
  • Teva Pharmaceuticals Usa
  • Aurobindo Pharma
  • Lupin Limited
  • Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd
  • Zydus Cadila
  • Torrent Pharmaceuticals Ltd
  • Cipla Ltd
  • Glenmark Pharmaceuticals
  • Alkem Laboratories
  • Granules India Ltd
  • Micro Labs Ltd

第14章 アナリストの提言

  • 「運命の輪」
  • アナリストの見解
  • Coherent Opportunity Map (COM)

第15章 参考文献と調査手法

  • 参考文献
  • 分析手法
  • Coherent Market Insightsについて
目次
Product Code: CMI8135

Losartan Market is estimated to be valued at USD 1.68 Bn in 2025 and is expected to reach USD 2.23 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 1.68 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.10% 2032 Value Projection: USD 2.23 Bn

The global Losartan market has witnessed significant growth in recent years, driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Losartan, an angiotensin II receptor antagonist, is widely prescribed for the treatment of high blood pressure, heart failure, and diabetic nephropathy. The market's expansion is further fueled by unhealthy lifestyles and rising awareness about the importance of effective blood pressure management. Moreover, the availability of generic Losartan products has increased their accessibility and affordability, contributing to their widespread adoption. As the demand for efficient antihypertensive medications continues to rise, the global Losartan market is poised for substantial growth in the coming years.

Market Dynamics

The global Losartan market is influenced by several key drivers, restraints, and opportunities. The primary driver for market growth is the increasing prevalence of hypertension and related cardiovascular disorders, such as heart failure and stroke. Unhealthy lifestyles characterized by sedentary behavior, obesity, and high-stress levels have led to a significant increase in the incidence of hypertension. Furthermore, the growing awareness about the importance of effective blood pressure management and the availability of affordable generic Losartan products have boosted the market's growth. However, the market also faces certain restraints, such as the presence of alternative antihypertensive medications and potential side effects associated with Losartan use. Additionally, the expiration of patents for branded Losartan products has led to increased competition from generic manufacturers, potentially impacting the market share of key players. Despite these challenges, the market presents promising opportunities for growth, including the development of novel drug delivery systems, the expansion of Losartan's therapeutic applications, and the untapped potential in emerging economies with high hypertension prevalence rates. Moreover, strategic collaborations and mergers among pharmaceutical companies are expected to drive innovation and expand market reach in the coming years.

Key features of the study

  • This report provides an in-depth analysis of the global Losartan market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global Losartan market based on the following parameters: company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd, Mylan N.V., Organon LLC, Alembic Pharmaceuticals Ltd, Macleods Pharmaceuticals Ltd, Teva Pharmaceuticals Usa, Aurobindo Pharma, Lupin Limited, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Ltd, Zydus Cadila, Torrent Pharmaceuticals Ltd, Cipla Ltd, Glenmark Pharmaceuticals, Alkem Laboratories, Granules India Ltd, and Micro Labs Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global Losartan market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Losartan market.

Market Segmentation

  • Indication Insights (Revenue, USD Bn, 2020 - 2032)
    • Hypertension
    • Left Ventricular Hypertrophy (LVH)
    • Diabetic Nephropathy
    • Others (Stroke, etc.)
  • Strength Insights (Revenue, USD Bn, 2020 - 2032)
    • 5 mg
    • 25 mg
    • 50 mg
    • 100 mg
  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Branded
    • Generic
  • Age Group Insights (Revenue, USD Bn, 2020 - 2032)
    • Pediatric
    • Adult
    • Geriatric
  • Gender Insights (Revenue, USD Bn, 2020 - 2032)
    • Male
    • Female
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Tablet
    • Powder
    • Suspension
  • Source Insights (Revenue, USD Bn, 2020 - 2032)
    • Contract Manufacturing Organizations
    • In-House Manufacturing
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U,S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Teva Pharmaceutical Industries Ltd
    • Mylan N.V.
    • Organon LLC
    • Alembic Pharmaceuticals Ltd
    • Macleods Pharmaceuticals Ltd
    • Teva Pharmaceuticals USA
    • Aurobindo Pharma
    • Lupin Limited
    • Reddy's Laboratories
    • Sun Pharmaceutical Industries Ltd
    • Zydus Cadila
    • Torrent Pharmaceuticals Ltd
    • Cipla Ltd
    • Glenmark Pharmaceuticals
    • Alkem Laboratories
    • Granules India Ltd
    • Micro Labs Ltd

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Losartan Market, By Indication
    • Global Losartan Market, By Strength
    • Global Losartan Market, By Product Type
    • Global Losartan Market, By Age Group
    • Global Losartan Market, By Gender
    • Global Losartan Market, By Distribution Channel
    • Global Losartan Market, By Form
    • Global Losartan Market, By Source
    • Global Losartan Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends
  • Treatment Option Analysis
  • Drug Resistance Scenario
  • Reimbursement Scenario
  • Regulatory Scenario

4. Global Losartan Market, By Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hypertension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Left Ventricular Hypertrophy (LVH)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diabetic Nephropathy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Stroke, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Losartan Market, By Strength, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • 5 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 25 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 50 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • 100 mg
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Losartan Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Branded
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Generic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Losartan Market, By Age Group, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Losartan Market, By Gender, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Male
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Female
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Losartan Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Losartan Market, By Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Suspension
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Losartan Market, By Source, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Contract Manufacturing Organizations
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • In-House Manufacturing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Losartan Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Indication, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

13. Competitive Landscape

  • Teva Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Organon LLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alembic Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Macleods Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceuticals Usa
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Aurobindo Pharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lupin Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Zydus Cadila
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Torrent Pharmaceuticals Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cipla Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Glenmark Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Alkem Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Granules India Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Micro Labs Ltd
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

14. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

15. References and Research Methodology

  • References
  • Research Methodology
  • About us